Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Validation of a mouse xenograft model system for gene expression analysis of human acute lymphoblastic leukaemia.

Samuels AL, Peeva VK, Papa RA, Firth MJ, Francis RW, Beesley AH, Lock RB, Kees UR.

BMC Genomics. 2010 Apr 21;11:256. doi: 10.1186/1471-2164-11-256.

2.

Evaluation of the NOD/SCID xenograft model for glucocorticoid-regulated gene expression in childhood B-cell precursor acute lymphoblastic leukemia.

Bhadri VA, Cowley MJ, Kaplan W, Trahair TN, Lock RB.

BMC Genomics. 2011 Nov 17;12:565. doi: 10.1186/1471-2164-12-565.

4.
5.

[Establishment of Human Acute B-Lymphoblastic Leukemia--NOD/SCID Xenotransplant Mouse Model].

Zhang X, Deng Y, Chen FL, Fang YJ, Zhang W, Yu L.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Jun;23(3):623-6. doi: 10.7534/j.issn.1009-2137.2015.03.004. Chinese.

PMID:
26117005
6.

Good engraftment of B-cell precursor ALL in NOD-SCID mice.

Baersch G, Möllers T, Hötte A, Dockhorn-Dworniczak B, Rübe C, Ritter J, Jürgens H, Vormoor J.

Klin Padiatr. 1997 Jul-Aug;209(4):178-85.

PMID:
9293448
7.

Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome.

Woiterski J, Ebinger M, Witte KE, Goecke B, Heininger V, Philippek M, Bonin M, Schrauder A, Röttgers S, Herr W, Lang P, Handgretinger R, Hartwig UF, André MC.

Int J Cancer. 2013 Oct 1;133(7):1547-56. doi: 10.1002/ijc.28170. Epub 2013 Apr 17.

8.

[Establishment of human acute B-lymphoblastic leukemia NOD/SCID/IL2 receptor γ chain(null) neonatal mouse xenotransplant model].

Kong Y, Liu YR, Liu KY, Huang XJ, Ishikawa F, Harada M.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Jun;20(3):762-8. Chinese.

PMID:
22739198
9.

Stability of gene expression and epigenetic profiles highlights the utility of patient-derived paediatric acute lymphoblastic leukaemia xenografts for investigating molecular mechanisms of drug resistance.

Wong NC, Bhadri VA, Maksimovic J, Parkinson-Bates M, Ng J, Craig JM, Saffery R, Lock RB.

BMC Genomics. 2014 Jun 1;15:416. doi: 10.1186/1471-2164-15-416.

10.

Successful engraftment by leukemia initiating cells in adult acute lymphoblastic leukemia after direct intrahepatic injection into unconditioned newborn NOD/SCID mice.

Cheung AM, Fung TK, Fan AK, Wan TS, Chow HC, Leung JC, Chan LY, Kwong YL, Liang R, Leung AY.

Exp Hematol. 2010 Jan;38(1):3-10. doi: 10.1016/j.exphem.2009.10.007.

PMID:
19837128
11.

Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice.

Nijmeijer BA, Mollevanger P, van Zelderen-Bhola SL, Kluin-Nelemans HC, Willemze R, Falkenburg JH.

Exp Hematol. 2001 Mar;29(3):322-9.

PMID:
11274760
12.

Successful engraftment of human acute lymphoblastic leukemia cells in NOD/SCID mice via intrasplenic inoculation.

Wang N, Huang L, Wang D, Wang J, Jiang L, Zhou K, Yang Y, Xu D, Zhou J.

Cancer Biol Ther. 2012 Oct;13(12):1158-64. doi: 10.4161/cbt.21345. Epub 2012 Aug 15.

13.

Human nasal polyp microenvironments maintained in a viable and functional state as xenografts in NOD-scid IL2rgamma(null) mice.

Bernstein JM, Brooks SP, Lehman HK, Pope L, Sands A, Shultz LD, Bankert RB.

Ann Otol Rhinol Laryngol. 2009 Dec;118(12):866-75.

14.

Generation of Pediatric Leukemia Xenograft Models in NSG-B2m Mice: Comparison with NOD/SCID Mice.

Gopalakrishnapillai A, Kolb EA, Dhanan P, Bojja AS, Mason RW, Corao D, Barwe SP.

Front Oncol. 2016 Jun 27;6:162. doi: 10.3389/fonc.2016.00162. eCollection 2016.

15.

Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.

Agliano A, Martin-Padura I, Mancuso P, Marighetti P, Rabascio C, Pruneri G, Shultz LD, Bertolini F.

Int J Cancer. 2008 Nov 1;123(9):2222-7. doi: 10.1002/ijc.23772.

16.

Oral or parenteral administration of curcumin does not prevent the growth of high-risk t(4;11) acute lymphoblastic leukemia cells engrafted into a NOD/SCID mouse model.

Zunino SJ, Storms DH, Newman JW, Pedersen TL, Keen CL, Ducore JM.

Int J Oncol. 2013 Feb;42(2):741-8. doi: 10.3892/ijo.2012.1734. Epub 2012 Dec 12.

17.

High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias.

Morisot S, Wayne AS, Bohana-Kashtan O, Kaplan IM, Gocke CD, Hildreth R, Stetler-Stevenson M, Walker RL, Davis S, Meltzer PS, Wheelan SJ, Brown P, Jones RJ, Shultz LD, Civin CI.

Leukemia. 2010 Nov;24(11):1859-66. doi: 10.1038/leu.2010.184. Epub 2010 Aug 26.

18.

[Establishment of mouse model with humanized Philadelphia chromosome-positive acute lymphoblastic leukemia].

Kong Y, Wang YZ, Hu Y, Huang XJ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Feb;22(1):73-7. doi: 10.7534/j.issn.1009-2137.2014.01.016. Chinese.

PMID:
24598655
19.

Growth of human T-cell lineage acute leukemia in severe combined immunodeficiency (SCID) mice and non-obese diabetic SCID mice.

Steele JP, Clutterbuck RD, Powles RL, Mitchell PL, Horton C, Morilla R, Catovsky D, Millar JL.

Blood. 1997 Sep 1;90(5):2015-9.

Supplemental Content

Support Center